Concepedia

C K Lynott

CK

Statistics

Publications

5

Citations

1.2K

H-Index

5

Active since

1993

Affiliations

Nivalis Therapeutics (United States)(Current)

C K Lynott is an author at Nivalis Therapeutics (United States) specializing in ligand binding, life sciences, and drug discovery.

Publications per year

1993–2006

5

Publications

5

Tumor targeting by an aptamer.

Brian J. Hicke, Andrew Stephens, Ty Gould et al. · PubMed · 2006 · 383 citations

, , +17

Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein

Brian J. Hicke, C. Marion, Ying-Fon Chang et al. · Journal of Biological Chemistry · 2001 · 321 citations · Full text

, , +14

Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor

Derek Jellinek, Louis S. Green, Carol Bell et al. · Biochemistry · 1995 · 214 citations

, , +13

High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.

Derek Jellinek, C K Lynott, Daniel B. Rifkin et al. · Proceedings of the National Academy of Sciences · 1993 · 149 citations

, , +16

DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.

Brian J. Hicke, Susan R. Watson, Andrea Koenig et al. · Journal of Clinical Investigation · 1996 · 132 citations · Full text

, , +17

1–5 of 5